Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ctDNA Monitoring”

125 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 125 results

Testing effectiveness (Phase 2)Ended earlyNCT04720729
What this trial is testing

Chemotherapy Monitoring by ctDNA in HER2- Metastatic Breast Cancer

Who this might be right for
HER2-negative Metastatic Breast Cancer
Institut Curie 160
Not applicableNot Yet RecruitingNCT07776483
What this trial is testing

Personalized ctDNA Monitoring for Predicting Immunotherapy Outcomes in Advanced Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Non-Clear Cell Renal Cell Carcinoma
West China Hospital 67
Not applicableStudy completedNCT04560270
What this trial is testing

CIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic Cancer

Who this might be right for
Pancreatic CancerCirculating Tumor DNAKRAS Mutation-Related Tumors
Poitiers University Hospital 69
Not applicableNot Yet RecruitingNCT07254156
What this trial is testing

Tumor-Agnostic MRD Detection in Stage III Colorectal Cancer

Who this might be right for
Colorectal CancerMRDctDNA
Sun Yat-sen University 229
Not applicableStudy completedNCT04238130
What this trial is testing

Evaluation ctDNA in Patients of Non-Small-Cell Lung Cancer Following Resection

Who this might be right for
Non-Small Cell Lung Cancer
Sun Yat-sen University 132
Not applicableLooking for participantsNCT06227728
What this trial is testing

Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.

Who this might be right for
Non Small Cell Lung CancerBreast CancerColorectal Cancer+4 more
Gene Solutions 50
Not applicableLooking for participantsNCT05196087
What this trial is testing

Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)

Who this might be right for
Breast CancerMelanomaGastrointestinal Neuroendocrine Tumor
University Health Network, Toronto 500
Testing effectiveness (Phase 2)Looking for participantsNCT06954805
What this trial is testing

Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

Who this might be right for
LymphomaLymphoma, B-Cell
Jennifer Amengual 30
Not applicableLooking for participantsNCT04353557
What this trial is testing

CtDNA Monitoring in Early Breast Cancer

Who this might be right for
Breast Cancer
Geneplus-Beijing Co. Ltd. 200
Not applicableUnknownNCT06025045
What this trial is testing

Dynamic Monitoring of ctDNA Predicts Recurrence of Advanced Ovarian Cancer After Primary Treatments

Who this might be right for
Ovarian Cancer Stage IVOvarian Cancer Stage III
Jing Li 50
Not applicableNot Yet RecruitingNCT07152535
What this trial is testing

Multi-omics Monitoring of Dynamic Evolution in Esophageal Squamous Cell Carcinoma: PKU-ESCC-Monitor

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Peking University Cancer Hospital & Institute 255
Very early researchStudy completedNCT03311958
What this trial is testing

Molecular Monitoring With Circulating Tumor DNA and Nivolumab Maintenance

Who this might be right for
Diffuse Large B Cell Lymphoma
Fox Chase Cancer Center 15
Not applicableStudy completedNCT06404593
What this trial is testing

Dynamic ctDNA Detection for Colorectal Cancer Liver Metastases

Who this might be right for
Liver MetastasesColorectal CancerSurgery+2 more
Peking University Cancer Hospital & Institute 270
Not applicableLooking for participantsNCT07829081
What this trial is testing

Research on Effective Strategies After Immunotherapy for Mismatch Repair-deficient Early-stage GI Tumors

Who this might be right for
Quality of Life (QOL)Mismatch Repair Deficient Colorectal CancerMicrosatellite Instability-High Colorectal Cancer+8 more
University Hospital, Basel, Switzerland 234
Not applicableStudy completedNCT05823584
What this trial is testing

Cell-free DNA From Junction of Hepatitis B Virus Integration in HCC Patients for Monitoring Post-resection Recurrence

Who this might be right for
Hepatocellular Carcinoma
TCM Biotech International Corp. 207
Not applicableLooking for participantsNCT06893133
What this trial is testing

CtDNA-MRD Monitoring After Resection in Gastric Cancer

Who this might be right for
Gastric Cancer
Peking University 110
Not applicableNot Yet RecruitingNCT05871593
What this trial is testing

CIRculating Cell-free nUcLeic Acids in Cancer Therapy Monitoring -01

Who this might be right for
Next-Generation-Sequencing
University Hospital Tuebingen 200
Not applicableLooking for participantsNCT06875609
What this trial is testing

CtDNA in Cutaneous Squamous Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell Carcinoma
Massachusetts Eye and Ear Infirmary 60
Not applicableLooking for participantsNCT06230185
What this trial is testing

CtDNA Based MRD Testing for NAC Monitoring in TNBC

Who this might be right for
TNBC - Triple-Negative Breast CancerMinimal Residual Disease
Personalis Inc. 422
Not applicableStudy completedNCT02169349
What this trial is testing

Molecular Diagnosis on Circulating Tumor DNA of Non-Small Cell Lung Cancer

Who this might be right for
Stage IIIb and IV Non Small Cell Lung Cancer
Rennes University Hospital 100
Next Page